Pathfinder Therapeutics, Inc. (PTI) is the developer of ExplorerTM, an image-guided “GPS” device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resection and/or ablation) in soft-tissue organs.
ExplorerTM is the first medical device cleared by the FDA in the category of Intraoperative Soft Tissue Tracking. ScoutTM, our advanced 3D planning software, provides highly detailed visual and volumetric information for preoperative assessment, thus enabling clinicians to visualize the site of disease, plan the resection and/or ablation and monitor the resultant effects. Read More>
Pathfinder sponsors Symposium on Hepatic Oncology Pathfinder is pleased to announce the sponsorship of an upcoming hepatic oncology symposium in Whistler, British Columbia, February 2-4, 2012. Read More>
Pathfinder is pleased to announce the sponsorship of an upcoming hepatic oncology symposium in Whistler, British Columbia, February 2-4, 2012.
Navigated ultrasound device successfully launched In collaboration with Hitachi Aloka Medical, Ltd, Pathfinder has successfully launched Shadow, a navigated intraoperative ultrasound device for use with the image-guided liver surgery platform ExplorerTM. Read More>
In collaboration with Hitachi Aloka Medical, Ltd, Pathfinder has successfully launched Shadow, a navigated intraoperative ultrasound device for use with the image-guided liver surgery platform ExplorerTM.
Pathfinder announces image guidance installations at UPMC and NIH Pathfinder is pleased to announce that it has finalized the acquisition of its image guided surgery platform at University of Pittsburgh Medical Center (UPMC) and the National Institute of Health (NIH). Read More>
Pathfinder is pleased to announce that it has finalized the acquisition of its image guided surgery platform at University of Pittsburgh Medical Center (UPMC) and the National Institute of Health (NIH).